RxDoctor Payments Data

Evgeniya Angelova, MD

Anatomic Pathology & Clinical Pathology · Red Bank, NJNPI 1447505367

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $142,000 of the $142,079 with a category attached, or 99.9%. Y-mabs Therapeutics, Inc. accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. 2024 is the largest year on record at $98,457, more than ten times the $22 reported in 2021. Among anatomic pathology & clinical pathology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,079in general payments, 2019–2025

Across 9 payments — averaging $15,787 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Y-mabs Therapeutics, Inc.$142K
  • AstraZeneca$44
  • Astellas Pharma US Inc$19
  • Myriad Genetic Laboratories, Inc.$16
$28,000in research payments, 2019–2025

Across 1 payment — averaging $28,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Y-mabs Therapeutics, Inc.$28K

What the payments were for

  • Consulting fees$142,000100%
  • Food & beverage$790%

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,079 in reported general payments places this provider in the 95th percentile of 218 anatomic pathology & clinical pathology providers in New Jersey.

See all anatomic pathology & clinical pathology providers in New Jersey

Medicare billing

Part B allowed, 2024
$298,761
Medicare patients
1,235
Services billed
6,714

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Red Bank

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →